• Poster

Cost-effectiveness of Dabigatran Etexilate 150mg for the Prevention of Venous Thromboembolism in Patients Undergoing Total hip or Knee Arthroplasty with Moderate Impairment of Renal Function

Citation

Wolowacz, S. E., Roskell, N. S., Plumb, J. M., Clemens, A., Robinson, P., Dolan, G., & Brenkel, I. J. (2009, May). Cost-effectiveness of Dabigatran Etexilate 150mg for the Prevention of Venous Thromboembolism in Patients Undergoing Total hip or Knee Arthroplasty with Moderate Impairment of Renal Function. Presented at ISPOR 14th Annual international Meeting, .

Abstract